Marqeta Announces May 2024 Investor Conference Presentations
Get Alerts MQ Hot Sheet
Join SI Premium – FREE
OAKLAND, Calif.--(BUSINESS WIRE)-- Marqeta (NASDAQ: MQ), the global modern card issuing platform that enables embedded finance solutions for the world’s innovators, today announced its executives are participating in two upcoming investor conferences.
Mike Milotich, Marqeta CFO, will participate in a fireside chat at the Barclays 14th Annual Emerging Payments and FinTech Forum on Thursday, May 16, 2024, at 9:45 a.m. Eastern Time.
Simon Khalaf, Marqeta CEO, will participate in a fireside chat at the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference on Monday, May 20, 2024, at 1:10 p.m. Eastern Time.
A live webcast and replay will be available on Marqeta’s investor relations website at investors.marqeta.com.
About Marqeta (NASDAQ: MQ)
Marqeta’s modern card issuing platform empowers its customers to create customized and innovative payment cards and embedded finance offerings. Marqeta’s platform, powered by open APIs, gives its customers the ability to build more configurable and flexible payment experiences, accelerating product development and democratizing access to card issuing technology. Its modern architecture provides instant access to highly scalable, cloud-based payment infrastructure that enables customers to launch and manage their own card programs, issue cards, and authorize and settle transactions. Marqeta is headquartered in Oakland, California, and is certified to operate in more than 40 countries globally. For more information, visit www.marqeta.com, Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515203908/en/
Media:
James Robinson
530-913-0844
[email protected]
Source: Marqeta
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hafnia’s Q2 2026 Financial Results Presentation to Be Held on 28 August 2026
- 3D Files Petition for Provisional Disposition Order Seeking Injunction Against the Invoking of Toho HD’s Poison Pill
- Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
JPMorgan, Barclays, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share